If someone hires a former Facebook employee to work on their social network, is that patent infringement?

No. If that employee then implements features that FB has patented? Probably yes.

I know it’s a pain, but what’s to stop us from using download-clis?

The answer is right there.

deleted by creator

1. It’s page one, so I don’t think this is a selected subset.

2. This is just the people playing right now, and only people playing on steam. This doesn’t show all of the people who bought the game or are playing on console.

3. Obviously none of the gaming boycotts have worked, and we’re both putting way too much thought into one image.

For anyone wondering: First number is base, second is related, third is other. I have no clue what those terms mean.

https://projects.propublica.org/nonprofits/organizations/824506840

Probably when it was beaten in both features and cost by the alternatives.

In other news, snow blindness is on the rise in suburbia.

It would solve so many problems over there, honestly.

Which ones?

Always has been. In many ways, Lemmy resembles the Reddit of 10 years ago.

Pfizer conducts research in various areas, including MS therapy. That costs a lot of money.

Like when Roche refused to study Rituximab in multiple sclerosis, which has been succesfully used as an off-label medication for more than a decade, and then released Ocrelizumab for MS, a totally different and not at all virtually identical drug for ten times the price?

Pfizer has a profit margin of ~30%, and that’s after lobbying and advertising and the billions of fines they had to pay for illegal advertising and kickbacks. Unsurprisingly, extractable profit is a really bad proxy for people’s health.

But I can’t complain anyway, here in Germany you can get Paxlovid free of charge because it’s prescribed by a doctor.

While I usually think the “free at point of service”-argument isn’t necessary, it’s very relevant here. You’re still paying for it, and all the other drugs that have come out over the last few years that are much, much more expensive than the therapies they replace.

Take a look at GLP-1-agonists (Wegovy, Ozempic, …) which will come to replace/combine with oral antidiabetics like metformine and have now also been approved for obesity without diabetes.

Metformine is basically free a 10ct/pill, i.e. ~3€/patient/month. GLP-1-agonists cost about 250 - 1000€/patient/month. More than half of the German population is overweight, and more than one in eight suffer from type 2 diabetes - with both figures on the rise.

This trend of massive price increases with every new generation of drugs is extremely dangerous healthcare systems themselves, especially public ones, and of course the patients themselves in the end. Every price hike sets a new baseline, and we need to be very, very careful about compounding effects.

This calls for Bloonface’s rebuttal. (Which is older than the talk, but refers to the same concept by the same person. I’m going to assume most points still apply.)